Aurinia Pharmaceuticals (AUPH) Return on Sales [ROS] (2019 - 2026)
Aurinia Pharmaceuticals (AUPH) posted Return on Sales [ROS] of 55.68% for Q2 2026, up 27.00 percentage points from 28.69% a year earlier and up 2.38 percentage points from the prior quarter.
Aurinia Pharmaceuticals (AUPH) Return on Sales [ROS] (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Aurinia Pharmaceuticals was 48.39%, up 28.40 percentage points year-over-year; for FY2025, it came in at 37.06%, up 39.06 percentage points from FY2024.
- Annual Return on Sales [ROS] has increased for four consecutive years, with a five-year change of +245.52 percentage points (FY2020 to FY2025).
- In prior years, Aurinia Pharmaceuticals' Return on Sales [ROS] was -1.99% in FY2024 (+50.25 pp), -52.24% in FY2023 (+30.93 pp), -83.17% in FY2022 (+313.14 pp) and -396.31% in FY2021 (-187.85 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Sales [ROS] in data going back to Q4 2019.
- On a year-over-year basis, Return on Sales [ROS] has increased in each of the last 11 quarters, with an average year-over-year change of +39.65 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q3 2021, with a gain of 145570.48 percentage points; the weakest was Q4 2021, with a drop of 123.65 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was 53.31% (Q1 2026), 43.10% (Q4 2025) and 40.49% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Aurinia Pharmaceuticals | 2.10 Bn | 532.21 Mn | 76.67 Mn | 55.68% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.68% |
| Mar 31, 2026 | 53.31% |
| Dec 31, 2025 | 43.10% |
| Sep 30, 2025 | 40.49% |
| Jun 30, 2025 | 28.69% |
| Mar 31, 2025 | 34.97% |
| Dec 31, 2024 | -2.79% |
| Sep 30, 2024 | 17.33% |
| Jun 30, 2024 | -2.65% |
| Mar 31, 2024 | -26.35% |
| Dec 31, 2023 | -65.80% |
| Sep 30, 2023 | -29.83% |
| Jun 30, 2023 | -38.97% |
| Mar 31, 2023 | -85.98% |
| Dec 31, 2022 | -98.82% |
| Sep 30, 2022 | -17.03% |
| Jun 30, 2022 | -127.66% |
| Mar 31, 2022 | -175.18% |
| Dec 31, 2021 | -139.74% |
| Sep 30, 2021 | -343.31% |
Aurinia Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AUPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "AUPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AUPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();